Federico Rojo (F Rojo)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Ejection Fraction

Prostate Cancer

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

Journal of clinical medicine

The journal of pathology. Clinical research

This page only lists publications with an associated author ORCID identifier.

Publications

Joan Albanell, José Manuel Peréz-García, Juan Miguel Gil-Gil, Curigliano Giuseppe, Manuel Ruiz Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet-Ezquerra, Begoña Bermejo, Lourdes Calvo Martinez, Juan R De la Haba-Rodríguez, Enrique Espinosa, Alessandro Marco Marco Minisini, Vanesa Quiroga, Ana Santaballa Bertran, Leonardo Mina, Beatriz Bellosillo, Federico Rojo, Silvia Menéndez, Miguel Sampayo, Ramona Mihaela Popa, Andrea Malfettone, Javier Cortes, Antonio Llombart
Palbociclib Rechallenge for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Karama Asleh, Ana Lluch, Angela Goytain, Carlos Henrique Barrios, Xue Qi Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz Borrego, Samuel C Y Leung, Jose Bines, Angel L Guerrero-Zotano, José Angel García-Saenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres, Juan R De la Haba-Rodríguez, Francisco Ayala, Henry L Gómez, Federico Rojo, Torsten O Nielsen, Miguel Martin
Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
David Gonzalez de Castro, Joaquin Mateo, Albrecht Stenzinger, Federico Rojo, Michelle Shiller, Alexander W Wyatt, Frédérique M Penault-Llorca, Leonard G Gomella, Rosalind A Eeles, Anders Bjartell
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer. The journal of pathology. Clinical research 7 (4) (2021)
Vicente Peg, María Ángeles López-García, Laura Comerma, Gloria Peiró, Tomás García-Caballero, Ángel Concha López, Ana Suárez-Gauthier, Irune Ruiz, Federico Rojo
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion. Future oncology (London, England) 17 (10) (2020)
Ion Cristóbal, Blanca Torrejón, Jaime Rubio, Andrea Santos, Manuel Pedregal, Cristina Caramés Sánchez, Sandra Zazo, Melani Luque, Marta Sanz-Alvarez, Juan Madoz-Gúrpide, Federico Rojo, Jesús García-Foncillas
Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. Journal of clinical medicine 8 (3) (2019)
Laura Nájera-Botello, Miguel Alonso-Juarranz, María-Concepción Garrido-Ruíz, C Ballestín, L Moya, M Martínez-Díaz, R Carrillo, Ángeles Juarranz de la Fuente, Federico Rojo, José M Cuezva, José Luis Rodriguez-Peralto
Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma. The British journal of dermatology 181 (1) (2019)